A GLP-1 program is not a single transaction. Someone reviews your history, someone decides whether to prescribe, a pharmacy dispenses the medicine, and a care team handles questions afterward. Joi+Blokes markets those steps as a connected experience, with medication programs, coaching and home delivery. Its terms, however, describe a platform connecting patients with independent medical providers rather than a company that directly practices medicine. Understanding that distinction is the starting point for evaluating what you would actually receive.
This review follows that care pathway using public documentation consulted October 19, 2026. Joi+Blokes documents compounded semaglutide, compounded tirzepatide, compounded liraglutide and a Zepbound service, alongside hormone and wellness offerings. The pages provide meaningful prices and service descriptions, but do not resolve every responsibility or payment boundary. The most consequential gaps concern which clinical and pharmacy entities serve an individual patient, how quickly support responds, and which cancellation and refund provisions govern a particular enrollment.
At a glance
- Who provides medical care
- Joi+Blokes says it does not practice medicine or directly provide healthcare; it connects users with third-party medical providers.Sources: [6]
- Compounded injection prices
- Compounded semaglutide is advertised at $179/month, with the first month $99; compounded tirzepatide is $249/month, with the first month $149. Both are billed quarterly and include medication, dosing support, clinician consultations and coaching.Sources: [5]
- Zepbound has separate medication costs
- The service costs $99/month, collected as $297 for three months, excluding medication. Listed Lilly Direct vial prices range from $349 to $699/month by presentation, are cash-pay only and are subject to change.Sources: [3]
- Geographic limits
- The company says treatment and medication shipping are limited to the United States, and specifically warns that compounded semaglutide is unavailable in some states.
Start by identifying the people behind the platform
Joi and Blokes identifies itself as the website’s owner and operator. Its terms explicitly separate that role from practicing medicine: third-party providers deliver the clinical services made available through the platform. The website names Melissa Loseke, DO, as medical director and Lauren Dulay, NP, as director of clinical operations and lead clinician. Those are company-published roles and credentials, not independent verification of the professional assigned to your care.
The consulted documentation does not identify the legal clinical group that would treat each patient or establish a complete state-by-state availability list. The company says it treats patients and ships medicines only within the United States; that statement should not be read as confirmation of coverage in every state. Its terms also limit services to people who have reached the age of majority in their jurisdiction of residence.
Before paying, ask for the treating organization’s name, the assigned clinician’s credentials and confirmation that the selected service is available where you will receive care. Our guide to clinicians and telehealth platforms explains why those identities matter. A medical director’s name gives organizational context, but does not establish who will review your history, issue a prescription or answer a later clinical question.
Intake leads to a clinical decision, not a guaranteed prescription
The advertised process begins with a health-history form and discussion of your needs with a licensed clinician. Partner providers then review the history and decide whether prescribing is appropriate. Joi+Blokes says every prescription product requires a consultation, which may be synchronous or asynchronous. In practical terms, the public description does not promise that every patient will have a live video appointment, nor does completing checkout establish that medication will be prescribed.
The terms require informed consent before telehealth services. They also allow a provider to determine that an issue needs an in-person visit or services unavailable through the platform. In that situation, the patient cannot continue using the service for that particular medical issue. This is a meaningful care boundary: the online pathway can end after review, and the documentation does not establish a coordinated referral or in-person appointment arrangement.
The pages do not publish detailed BMI criteria, comorbidity requirements or a complete set of clinical exclusions for these programs. Those missing details are not evidence that there are no restrictions. Prepare a medication and supplement list and questions about the consultation format, records needed and next steps if online care is unsuitable. The first-consultation preparation guide can help organize that conversation without presuming that any particular treatment is appropriate.
The selected product changes both the care route and the bill
Joi+Blokes advertises subcutaneous compounded semaglutide and compounded tirzepatide injections. Its semaglutide disclosure says concentrations and additional ingredients, such as B12, glycine or L-carnitine, depend on individual clinical needs. It separately offers compounded liraglutide as a subcutaneous injection. These are specific compounded offerings, not interchangeable descriptions of branded products. Ask which formulation is proposed and which pharmacy will dispense it before assuming an ingredient name tells the whole story.
The semaglutide and tirzepatide prices include medication, dosing support, clinician consultations and health coaching, but are billed quarterly despite being displayed as monthly amounts. The pages do not specify the exact initial quarterly charge after applying the first-month discount. Liraglutide is advertised at $299/month with virtual visits, personalized coaching, lab access and continuous support; the quoted package description does not separately clarify the medication-charge boundary or the billing interval beyond that monthly figure.
The Zepbound service has a clearer separation: $297 pays for three months of service, not the medication. Its published vial prices are $349/month for 2.5 mg, $499 for 5 mg, $599 for 7.5 mg and $699 for 10 mg. These are presentation-specific commercial listings, not dosing guidance. The listed vials are purchased through Lilly Direct, cash-pay only, without insurance coverage, and prices may change.
| Offering | Advertised charge | What to clarify |
|---|---|---|
| Compounded subcutaneous semaglutide | $179/month; first month $99; billed quarterly | Exact first quarterly collection; medication and listed support included |
| Compounded subcutaneous tirzepatide | $249/month; first month $149; billed quarterly | Exact first quarterly collection; medication and listed support included |
| Compounded subcutaneous liraglutide | $299/month | Medication-charge boundary, billing interval and lab charges |
| Zepbound service | $99/month, collected as $297 for three months | Medication excluded; visits, coaching, lab access and support listed |
| Zepbound injection vials through Lilly Direct | $349/month: 2.5 mg; $499: 5 mg; $599: 7.5 mg; $699: 10 mg | Cash-only listed channel; no insurance coverage for these vials; prices subject to change |
Laboratory access and insurance assistance are not the same as coverage
The compounded-program page says laboratory testing is not required, and the Zepbound page likewise describes testing as optional. Zepbound lists Complete Hormone, Advanced and Comprehensive panels for people seeking additional information. A shared website module asks how testing should be arranged, but that question does not establish a mandatory blood draw for a particular medicine. Nor does the phrase “lab access” establish that tests, collection or interpretation are included without additional charges.
Diagnostic pricing has its own conditions. The website advertises 65% off diagnostic labs for new customers using LABS65, without an expiration date in the consulted banner. It also says New York and New Jersey have different diagnostic prices because of local requirements. Diagnostic lab purchases and lab subscriptions are described as final and nonrefundable. Request the actual panel, location-specific price and refund terms before adding testing to a medication enrollment.
Joi+Blokes says it helps with prior authorizations and prescription submissions but does not bill insurers directly. General statements that branded medicines may qualify for coverage do not override the cash-only terms for the listed Lilly Direct Zepbound vials. The site also offers eligible HSA/FSA payments through Flex, subject to verification and approval of a letter if required; any remaining balance can be paid using a secondary method. That is conditional payment support, not a blanket eligibility guarantee.
The pharmacy handoff has several possible branches
The terms list Strive Pharmacy, Pharmacy Hub, Tailor Made Compounding Pharmacy, Cadre Labs LLC, Empower Pharmacy, LillyDirect Self Pay Pharmacy Solutions doing business as GiftHealth, and Partell Pharmacy as partners dispensing prescriptions to patients’ doors. This is a partner list, not confirmation that each pharmacy prepares every advertised formulation. Dispensing also does not necessarily mean compounding. The documentation does not establish which partner would fulfill an individual compounded prescription.
There is an outside-pharmacy route in the terms: Joi+Blokes says it will send the prescription to a selected pharmacy, but the patient then handles obtaining the product and paying that pharmacy directly. Do not assume an advertised medication-inclusive package transfers unchanged to that arrangement. The pharmacy handoff guide provides questions about the dispensing entity, formulation, separate charges and whom to contact when a prescription or shipment needs correction.
For Zepbound, the product page describes a specific post-approval handoff: a text from Lilly Direct supplies instructions to complete the medication purchase. That extra transaction matters because paying the platform’s service charge is not the same as paying for medication. Before enrollment, clarify who resolves a missing text, purchase problem or pharmacy delay, and whether the service period begins before the separate medication transaction has been completed.
Home delivery needs a plan for timing and problems
Joi+Blokes advertises medication delivery to your door. The Zepbound page goes further, saying that after approval patients are connected by text to pay and receive medication within 72 hours. That is the provider’s advertised post-approval purchase-and-receipt timeline, not a promise that clinical review finishes within 72 hours. The consulted documentation does not establish general preparation or delivery times for compounded semaglutide, compounded tirzepatide or liraglutide.
The public materials do not specify cold-chain arrangements or replacement rules for lost, damaged or inadequately refrigerated shipments. FDA advises not using an injectable GLP-1 medicine that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. Our guide to warm injectable deliveries explains that advice. A useful pre-purchase question is which contact handles shipment concerns and what happens to the bill while a problem is investigated.
Packaging deserves a separate check. The terms warn that partner-pharmacy prescriptions may not use child-resistant packaging or containers. They also state that prescription products cannot be returned and sales are final. A no-return rule does not explain how a dispensing error or damaged delivery will be corrected. Ask about that process explicitly, including the responsible party and documentation needed, rather than assuming the ordinary return policy supplies a replacement guarantee.
Ongoing support is broad on paper, less specific on timing
The compounded programs advertise unlimited health-coach visits, clinician access and support, nutrition and lifestyle recommendations, unlimited messaging and a community. These are meaningful listed services, but they are not all medical care. Joi+Blokes expressly says health coaches are not doctors and cannot prescribe, diagnose or provide specific medical advice. A question about medication tolerance therefore needs a clinical route, not simply access to the next available coaching session.
The terms caution that communication with providers may not occur in real time. The consulted pages do not establish a guaranteed response window, scheduled review frequency or prescription-renewal cadence. Ask how a message reaches a prescribing clinician, what happens outside ordinary support hours and whether follow-up is scheduled or patient-initiated. “Unlimited” describes access volume; it does not by itself establish immediate availability, continuity with one clinician or a particular appointment interval.
Clinical follow-up should address response and tolerability, not merely the next payment. NIDDK describes medication selection as a discussion of benefits, side effects, health conditions, other medicines, family history and costs. FDA also notes that compounded preparations are not FDA approved and recommends them when an individual’s medical needs cannot be met by an approved drug. Nonapproval alone does not establish clinical inequivalence, but the provider’s support promises do not establish product-specific outcomes either.
Resolve cancellation and refund conflicts before the first charge
The compounded-program page advertises no membership fees and the ability to adjust or cancel a plan anytime. General subscription terms, however, require payment for at least three consecutive months and automatic charging as described for the product. They allow cancellation thirty days before the next monthly processing date after the initial commitment. The public documentation does not reconcile that monthly-processing language with quarterly billing or establish which provision controls each specific purchase.
Refund language is also inconsistent across pathways. The prescription page promises an immediate refund if prescribing is not appropriate. The insurance-supported GLP-1 policy instead says subscriptions can be canceled anytime but fees already paid are nonrefundable, even if the person is not a candidate or does not obtain approval. These may concern different arrangements, but the consulted pages do not clearly map the boundaries. An immediate-refund statement also does not establish when money reaches a bank account.
Ask for written confirmation identifying your exact program, initial collection, renewal date, minimum commitment, cancellation deadline and what is refundable if no prescription results. Cancellation stops a service under its applicable rules; it does not automatically reverse past charges. Because continued care may involve both a platform subscription and a separate pharmacy purchase, also ask what happens to pending prescriptions, outstanding clinical questions and already-paid service time when the platform enrollment ends.
Questions & answers
Will my Joi+Blokes consultation be a live video visit?
Not necessarily. The website allows either synchronous or asynchronous consultation with a licensed provider. It does not establish the format every patient receives or a guaranteed appointment window. Ask which format applies to your selected program and how you can raise questions before the prescribing decision.
Does the $99/month Zepbound service include the medicine?
No. The service is collected as $297 for three months and lists virtual visits, personalized coaching, lab access and continuous support. Medication is separate. The page directs approved patients to Lilly Direct for a purchase and lists cash-only vial prices by presentation, explicitly excluding insurance coverage for those vials.
Are blood tests mandatory for the compounded or Zepbound programs?
The relevant product pages say labs are not required. Zepbound offers three optional panels, while other package descriptions refer to lab access without defining all included charges. A shared testing-arrangement question does not establish a mandatory blood draw. Confirm whether your clinician requests testing and obtain its actual price before purchasing it.
Can I choose a pharmacy outside the partner network?
The terms describe that option: the prescription can be sent to your selected pharmacy, but you are responsible for obtaining the medication and paying that pharmacy directly. They do not establish that every advertised package price remains unchanged in this arrangement. Confirm prescription availability and the platform’s remaining service charge before choosing this route.
Can a health coach change my prescription?
No. Joi+Blokes says its health coaches cannot prescribe, diagnose or provide specific medical advice. The compounded programs also advertise clinician access, but the pages do not specify a guaranteed clinical response time. Ask how medication questions are escalated from coaching or general messaging to the professional responsible for prescribing.
Will I get a refund if I am not prescribed medication?
The answer is not consistent across the public documents. One prescription page promises an immediate refund when prescribing is inappropriate; the insurance-supported GLP-1 policy says paid subscription fees remain nonrefundable even without candidacy or approval. Obtain written confirmation of the policy governing your specific enrollment rather than relying on either statement in isolation.
Our assessment
Joi+Blokes documents more than a medication checkout: its advertised pathway includes clinical review, several prescription options, pharmacy fulfillment, coaching and ongoing messaging. The separate Zepbound service and medication transaction is particularly important to understand, as are quarterly billing for compounded semaglutide and tirzepatide and the limits of coaching. The weaker points are operational specificity and consistency. Public documentation does not settle individual pharmacy assignment, follow-up timing, shipment-remedy procedures or competing cancellation and refund provisions. Those gaps do not prove poor care, but they prevent a fully predictable account of the patient experience. Before enrolling, obtain a written care-and-payment outline naming the treating entity, dispensing pharmacy, exact initial charge, clinical contact route and applicable exit terms. That would make the advertised connected service much easier to evaluate on its actual responsibilities.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Joi+Blokes — shop/women/weight loss/zepbound ↗
- Joi+Blokes — official website ↗
- Joi+Blokes — glp 1 ↗
- Joi+Blokes — terms ↗
- Joi+Blokes — shop/women/weight loss/liraglutide ↗
- Joi+Blokes — refunds and returns ↗